Details
Stereochemistry | ACHIRAL |
Molecular Formula | C40H52O2 |
Molecular Weight | 564.8397 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 9 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(\C=C\C=C(C)\C=C\C1=C(C)C(=O)CCC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)C(=O)CCC2(C)C
InChI
InChIKey=FDSDTBUPSURDBL-DKLMTRRASA-N
InChI=1S/C40H52O2/c1-29(17-13-19-31(3)21-23-35-33(5)37(41)25-27-39(35,7)8)15-11-12-16-30(2)18-14-20-32(4)22-24-36-34(6)38(42)26-28-40(36,9)10/h11-24H,25-28H2,1-10H3/b12-11+,17-13+,18-14+,23-21+,24-22+,29-15+,30-16+,31-19+,32-20+
Molecular Formula | C40H52O2 |
Molecular Weight | 564.8397 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 9 |
Optical Activity | NONE |
DescriptionSources: https://goo.gl/tDK1gACurator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/6432595 | https://www.ncbi.nlm.nih.gov/pubmed/3935496 | https://www.ncbi.nlm.nih.gov/pubmed/6819749 | https://www.ncbi.nlm.nih.gov/pubmed/22770743
Sources: https://goo.gl/tDK1gA
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/6432595 | https://www.ncbi.nlm.nih.gov/pubmed/3935496 | https://www.ncbi.nlm.nih.gov/pubmed/6819749 | https://www.ncbi.nlm.nih.gov/pubmed/22770743
Canthaxanthin is a keto-carotenoid pigment and potent lipid-soluble antioxidant widely distributed in nature. Canthaxanthin has been found in edible mushrooms green algae, bacteria, crustaceans, and bioaccumulates in fish such as carp, golden mullet, seabream and trash wrasse. Canthaxanthin is used to reduce sensitivity to sunlight (photosensitivity) experienced by people who have a rare genetic disease called erythropoietic protoporphyria (EPP). In these people, sunlight can cause skin reactions such as rash, itch, and eczema. Canthaxanthin is also used to reduce sun sensitivity caused by certain medications. Some people also try it for relieving itching caused by sun exposure. Canthaxanthin is associated with E number E161g and is approved for use as a food coloring agent in different countries, including the United States and the EU; however, it is not approved for use in Australia and New Zealand. It is generally authorized for feed applications in at least the following countries: US, Canada, EU. In the EU, canthaxanthin is allowed by law to be added to trout feed, salmon feed, and poultry feed. The European Union limit is 80 mg/kg of feedstuffs, 8 mg/kg feed for egg-laying hens and 25 mg/kg in feed for other poultry and salmonids.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL4302 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22770743 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Psoriasis and vitamin A. Plasma transport and skin content of retinol, dehydroretinol and carotenoids in adult patients versus healthy controls. | 1985 |
|
Plasma concentrations of beta-carotene and canthaxanthin during and after stopping intake of a combined preparation. | 1985 |
|
Aplastic anemia associated with canthaxanthin ingested for 'tanning' purposes. | 1990 Sep 5 |
|
Ah receptor-dependent CYP1A induction by two carotenoids, canthaxanthin and beta-apo-8'-carotenal, with no affinity for the TCDD binding site. | 1997 Jul 15 |
|
Interactions in the postprandial appearance of beta-carotene and canthaxanthin in plasma triacylglycerol-rich lipoproteins in humans. | 1997 Nov |
|
Ocular side effects from herbal medicines and nutritional supplements. | 2004 Oct |
|
A study in scarlet: enzymes of ketocarotenoid biosynthesis in the flowers of Adonis aestivalis. | 2005 Feb |
Sample Use Guides
In Vivo Use Guide
Sources: https://goo.gl/tDK1gA
For reducing and treating rash, itch, and/or eczema (symptoms of photosensitivity) in people with erythropoietic protoporphyria (EPP) when they are exposed to sunlight: 60 to 90 mg of canthaxanthin daily on average for three to five months per year.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22770743
Caco-2 cells (2 x 10^3 cells/well in 96-well plates) were incubated at 37 ◦C until a confluent monolayer was formed (after 4–6 days). Then cells were pre-incubated for 30 min at 37C with different concentrations of Canthaxanthin (1-200mkM). Verapamil was used as a positive substrate control. Cells were then incubated for 90 min with either rhodamine 123 (Rho123) (1 mkg/ml), or calcein-AM (150 nM); afterwards they were washed with substrate free medium. Rho123 and calcein fluorescence was measured at excitation/emission wavelengths of 485/535 nm using Tecan Safire IITM spectrofluorometer (Tecan Crailsheim, Germany). The same protocol was applied by using different concentrations of the substrate doxorubicin with and without selected carotenoids (40 mkM); fluorescence of doxorubicin was measured at excitation/emission wavelengths of 480/590.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:18:44 GMT 2023
by
admin
on
Fri Dec 15 15:18:44 GMT 2023
|
Record UNII |
4C3C6403MU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CODEX ALIMENTARIUS (GSFA) |
INS-161G
Created by
admin on Fri Dec 15 15:18:44 GMT 2023 , Edited by admin on Fri Dec 15 15:18:44 GMT 2023
|
||
|
DSLD |
1037 (Number of products:1)
Created by
admin on Fri Dec 15 15:18:44 GMT 2023 , Edited by admin on Fri Dec 15 15:18:44 GMT 2023
|
||
|
JECFA EVALUATION |
INS-161G
Created by
admin on Fri Dec 15 15:18:44 GMT 2023 , Edited by admin on Fri Dec 15 15:18:44 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m3026
Created by
admin on Fri Dec 15 15:18:44 GMT 2023 , Edited by admin on Fri Dec 15 15:18:44 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000076626
Created by
admin on Fri Dec 15 15:18:44 GMT 2023 , Edited by admin on Fri Dec 15 15:18:44 GMT 2023
|
PRIMARY | |||
|
374110
Created by
admin on Fri Dec 15 15:18:44 GMT 2023 , Edited by admin on Fri Dec 15 15:18:44 GMT 2023
|
PRIMARY | |||
|
SUB13228MIG
Created by
admin on Fri Dec 15 15:18:44 GMT 2023 , Edited by admin on Fri Dec 15 15:18:44 GMT 2023
|
PRIMARY | |||
|
C68309
Created by
admin on Fri Dec 15 15:18:44 GMT 2023 , Edited by admin on Fri Dec 15 15:18:44 GMT 2023
|
PRIMARY | |||
|
42348
Created by
admin on Fri Dec 15 15:18:44 GMT 2023 , Edited by admin on Fri Dec 15 15:18:44 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID0022727
Created by
admin on Fri Dec 15 15:18:44 GMT 2023 , Edited by admin on Fri Dec 15 15:18:44 GMT 2023
|
PRIMARY | |||
|
4C3C6403MU
Created by
admin on Fri Dec 15 15:18:44 GMT 2023 , Edited by admin on Fri Dec 15 15:18:44 GMT 2023
|
PRIMARY | |||
|
514-78-3
Created by
admin on Fri Dec 15 15:18:44 GMT 2023 , Edited by admin on Fri Dec 15 15:18:44 GMT 2023
|
PRIMARY | |||
|
208-187-2
Created by
admin on Fri Dec 15 15:18:44 GMT 2023 , Edited by admin on Fri Dec 15 15:18:44 GMT 2023
|
PRIMARY | |||
|
CANTHAXANTHIN
Created by
admin on Fri Dec 15 15:18:44 GMT 2023 , Edited by admin on Fri Dec 15 15:18:44 GMT 2023
|
PRIMARY | |||
|
D016644
Created by
admin on Fri Dec 15 15:18:44 GMT 2023 , Edited by admin on Fri Dec 15 15:18:44 GMT 2023
|
PRIMARY | |||
|
3362
Created by
admin on Fri Dec 15 15:18:44 GMT 2023 , Edited by admin on Fri Dec 15 15:18:44 GMT 2023
|
PRIMARY | |||
|
5281227
Created by
admin on Fri Dec 15 15:18:44 GMT 2023 , Edited by admin on Fri Dec 15 15:18:44 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |